HIC Analysis of Drug-to-Antibody Ratio

March 16, 2021
Agilent Technologies, Inc.

This application note demonstrates the DAR determination of brentuximab vedotin using HIC. Excellent reproducibility was found with the Agilent 1290 Infinity II Bio LC.